These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36477465)
1. Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy. Görtz GE; Philipp S; Bruderek K; Jesenek C; Horstmann M; Henning Y; Oeverhaus M; Daser A; Bechrakis NE; Eckstein A; Brandau S; Berchner-Pfannschmidt U Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36477465 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking. Görtz GE; Horstmann M; Aniol B; Reyes BD; Fandrey J; Eckstein A; Berchner-Pfannschmidt U J Clin Endocrinol Metab; 2016 Dec; 101(12):4834-4842. PubMed ID: 27610652 [TBL] [Abstract][Full Text] [Related]
3. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy. Lee CE; Choi SH; Yoon JS Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527 [TBL] [Abstract][Full Text] [Related]
4. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy. Lee JS; Chae MK; Kikkawa DO; Lee EJ; Yoon JS Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):51. PubMed ID: 32735324 [TBL] [Abstract][Full Text] [Related]
5. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy. Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734 [TBL] [Abstract][Full Text] [Related]
6. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy. Park M; Banga JP; Kim GJ; Kim M; Lew H Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042 [TBL] [Abstract][Full Text] [Related]
7. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy. Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS PLoS One; 2019; 14(8):e0221077. PubMed ID: 31415657 [TBL] [Abstract][Full Text] [Related]
9. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy. Dik WA; Virakul S; van Steensel L Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405 [TBL] [Abstract][Full Text] [Related]
10. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts. Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy. Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648 [No Abstract] [Full Text] [Related]
12. Pentraxin 3 mediates inflammation and adipogenesis in Graves' orbitopathy pathogenesis. Kim MS; Park HY; Choi SH; Chang EJ; Ko J; Yoon JS J Mol Endocrinol; 2024 Nov; 73(4):. PubMed ID: 39283923 [TBL] [Abstract][Full Text] [Related]
13. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662 [No Abstract] [Full Text] [Related]
14. Therapeutic role of histone deacetylase inhibition in an Byeon HJ; Choi SH; Kikkawa DO; Ko J; Yoon JS Mol Med Rep; 2024 Dec; 30(6):. PubMed ID: 39329199 [TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy. Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982 [TBL] [Abstract][Full Text] [Related]
16. M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor. Lu Y; Wang Y; Wang Y; Wu Y; Huang Y; Liu X; Zhang S; Zhong S; Li Y; Li B; Sun J; Fang S; Zhou H Thyroid; 2023 Mar; 33(3):338-350. PubMed ID: 36617890 [No Abstract] [Full Text] [Related]
17. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480 [TBL] [Abstract][Full Text] [Related]
18. Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy. Pawlowski P; Poplawska I; Mysliwiec J; Dik WA; Eckstein A; Berchner-Pfannschmidt U; Milewski R; Lawicki S; Dzieciol-Anikiej Z; Rejdak R; Reszec J Folia Histochem Cytobiol; 2020; 58(1):37-45. PubMed ID: 32176314 [TBL] [Abstract][Full Text] [Related]
19. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy. Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094 [No Abstract] [Full Text] [Related]
20. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy. Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]